Gene · 3598
Papers2,877
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,877
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Loss of IL13RA2 promotes metastatic tumor growth in triple-negative breast cancer via increased AKT and NF-κB signaling. | Clin Exp Metastasis | 2025 | 40663259 | PubTator, text mining | PubMed |
| Future Perspectives and Conclusions from Animal Models of CHI3L1-Related Inflammation-Associated Cancer. | Cells | 2025 | 40643503 | PubTator, text mining | PubMed |
| Targeting IL13Rα2 in melanoma with a bispecific T-cell engager: expression profiling and preclinical evaluation. | J Immunother Cancer | 2025 | 40484645 | PubTator, text mining | PubMed |
| Understudied Populations in Radiation Exposure Research: Needs, Challenges, and Mitigation Strategies. | Radiat Res | 2025 | 40462442 | PubTator, text mining | PubMed |
| Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial. | Nat Med | 2025 | 40451950 | PubTator, text mining | PubMed |
| Chimeric antigen receptor-macrophages: Emerging next-generation cell therapy for brain cancer. | Neurooncol Adv | 2025 | 40376682 | PubTator, text mining | PubMed |
| The immunopeptidomic landscape of ependymomas provides actionable antigens for T-cell-based immunotherapy. | Neurooncol Adv | 2025 | 40376681 | PubTator, text mining | PubMed |
| Interleukin-4 modulates type I interferon to augment antitumor immunity. | Sci Adv | 2025 | 40367186 | PubTator, text mining | PubMed |
| Dupilumab-associated lymphoproliferative disorders: a comprehensive review on clinicohistopathologic features and underlying mechanisms. | Curr Opin Immunol | 2025 | 40349527 | PubTator, text mining | PubMed |
| A peek into the pipeline: Expert views on emerging therapies. | Cell Rep Med | 2025 | 40239631 | PubTator, text mining | PubMed |
| Advancements and challenges in CAR T cell therapy for pediatric brain tumors: A review. | J Oncol Pharm Pract | 2025 | 40156311 | PubTator, text mining | PubMed |
| Expanding the Therapeutic Reach of Chimeric Antigen Receptor T-Cells and Bispecific T-Cell Engagers Across Solid Tumors. | JCO Precis Oncol | 2025 | 40138603 | PubTator, text mining | PubMed |
| CAR T cell therapy for glioblastoma: A review of the first decade of clinical trials. | Mol Ther | 2025 | 40057825 | PubTator, text mining | PubMed |
| IL13Rα2-Targeting Antibodies for Immuno-PET in Solid Malignancies. | J Nucl Med | 2025 | 39978817 | PubTator, text mining | PubMed |
| Pooled screening for CAR function identifies novel IL-13Rα2-targeted CARs for treatment of glioblastoma. | J Immunother Cancer | 2025 | 39933837 | PubTator, text mining | PubMed |
| Type-2 innate signals are dispensable for skeletal muscle regeneration and pathology linked to Duchenne muscular dystrophy. | EMBO Rep | 2025 | 39900735 | PubTator, text mining | PubMed |
| Personalized Medicine in Chronic Rhinosinusitis: Treatable Traits Using Biologics for Unmet Needs. | Allergy Asthma Immunol Res | 2025 | 39895599 | PubTator, text mining | PubMed |
| The Bidirectional Interplay between T Cell-Based Immunotherapies and the Tumor Microenvironment. | Cancer Immunol Res | 2025 | 39786986 | PubTator, text mining | PubMed |
| Clinical progress in the development of CAR T cells to treat malignant glioma. | J Neurooncol | 2025 | 39695004 | PubTator, text mining | PubMed |
| Interleukin-13 Receptor Subunit Alpha 2 Induces Chemokine Expression and Macrophage Polarization to Promote Inflammation and Fibrosis. | Int J Radiat Oncol Biol Phys | 2025 | 39672516 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3598/papers?page=7